UK Companies House feature
CHALICE MEDICAL LIMITED
Profile
- Company number
- 03625972
- Status
- Active
- Incorporation
- 1998-09-03
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Cooper Parry Group Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the Directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.”
Significant events
- “Turnover increased by 18% to £11.2m, this exceeded forecasts for the second consecutive year. Following a comprehensive financial review, gross profit margin improved to 33% (FY24: 28%), resulting in a 37% increase in gross profit to £3.7m (FY24: £2.7m).”
- “During FY25 we increased ECMO market share through the US launch of the CMO8 oxygenator. UKCA and EU MDR approvals were also obtained for the CMO8, and the first UK clinical use of the CMO8 occurred in September 2025.”
- “Chalice is proud to be among the first companies to achieve full MDR approval across its product range, a testament to the expertise of our regulatory and quality teams. Active pursuit of FDA registration for additional products will enable further growth opportunities in the US.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
6 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BOUSFIELD-CUNDY, Rachel | Secretary | 2008-09-01 | — | Other |
| BOUSFIELD-CUNDY, Philip William | Director | 1999-09-13 | Jan 1963 | British |
| BOUSFIELD-CUNDY, Rachel Mary | Director | 2016-09-15 | May 1973 | British |
| BOWNS, Lee | Director | 2018-03-23 | Dec 1982 | British |
| CUNDY, Harriett May | Director | 2025-11-03 | Apr 1998 | British |
| CUNDY, Lucy Victoria | Director | 2025-11-03 | Sep 1996 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOUSFIELD, Christine Anne | Secretary | 1999-09-13 | 2008-09-01 |
| REID, Brian | Secretary | 1998-09-03 | 1998-09-11 |
| RENUCCI-HART, Carole | Secretary | 1998-09-11 | 1999-09-13 |
| BLACKLOCK, Christopher | Director | 1998-09-11 | 2006-10-18 |
| MABBOTT, Stephen | Director | 1998-09-03 | 1998-09-11 |
| SHIPLEY, Richard James | Director | 2019-07-01 | 2024-02-23 |
| WATERS, David | Director | 2006-12-19 | 2016-07-22 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Philip William Bousfield | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 170 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-12-28 | AA | accounts | accounts with accounts type full |
| 2025-11-13 | AP01 | officers | appoint person director company with name date |
| 2025-11-13 | AP01 | officers | appoint person director company with name date |
| 2025-11-03 | CH01 | officers | change person director company with change date |
| 2025-11-03 | CH03 | officers | change person secretary company with change date |
| 2025-11-03 | CH01 | officers | change person director company with change date |
| 2025-09-16 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-12-19 | AA | accounts | accounts with accounts type full |
| 2024-12-10 | RESOLUTIONS | resolution | resolution |
| 2024-12-09 | SH06 | capital | capital cancellation shares |
| 2024-12-06 | SH03 | capital | capital return purchase own shares |
| 2024-10-15 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-06-21 | SH01 | capital | capital allotment shares |
| 2024-06-21 | RESOLUTIONS | resolution | resolution |
| 2024-03-28 | TM01 | officers | termination director company with name termination date |
| 2023-12-12 | AA | accounts | accounts with accounts type full |
| 2023-10-23 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2023-09-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-01-06 | AA | accounts | accounts with accounts type full |
| 2022-10-20 | MR04 | mortgage | mortgage satisfy charge full |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.